AXQ CAPITAL, LP

Position in LLY — ELI LILLY & Co

CIK 1916908 JERSEY CITY, NJ

Position in LLY

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,426,353

+$611,219 QoQ

Shares Held

2,638

+56.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AXQ CAPITAL, LP holds $4,540,742 across 4 Drug Manufacturers - General names. LLY ranks #1 (53.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	2,638	$2,426,353
2	BMY	Bristol Myers Squibb Co	30,117	$1,826,596
3	GRFS	Grifols SA	24,284	$194,757
4	OGN	Organon & Co.	15,532	$93,036

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,426,353	2,638	+56.2%	Shares	Sole	2026-05-13
2025-12-31	$1,815,134	1,689	-48.9%	Shares	Sole	2026-02-10
2024-09-30	$2,927,145	3,304	-2.8%	Shares	Sole	2024-11-14
2023-09-30	$1,826,242	3,400	+240.0%	Shares	Sole	2023-11-14
2023-03-31	$343,420	1,000	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.